Cargando…

Synthesized Mammography: Clinical Evidence, Appearance, and Implementation

Digital breast tomosynthesis (DBT) has improved conventional mammography by increasing cancer detection while reducing recall rates. However, these benefits come at the cost of increased radiation dose. Synthesized mammography (s2D) has been developed to provide the advantages of DBT with nearly hal...

Descripción completa

Detalles Bibliográficos
Autor principal: Durand, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023509/
https://www.ncbi.nlm.nih.gov/pubmed/29617294
http://dx.doi.org/10.3390/diagnostics8020022
_version_ 1783335885536755712
author Durand, Melissa A.
author_facet Durand, Melissa A.
author_sort Durand, Melissa A.
collection PubMed
description Digital breast tomosynthesis (DBT) has improved conventional mammography by increasing cancer detection while reducing recall rates. However, these benefits come at the cost of increased radiation dose. Synthesized mammography (s2D) has been developed to provide the advantages of DBT with nearly half the radiation dose. Since its F.D.A. approval, multiple studies have evaluated the clinical performance of s2D. In clinical practice, s2D images are not identical to conventional 2D images and are designed for interpretation with DBT as a complement. This article reviews the present literature to assess whether s2D is a practical alternative to conventional 2D, addresses the differences in mammographic appearance of findings, and provides suggestions for implementation into clinical practice.
format Online
Article
Text
id pubmed-6023509
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60235092018-07-13 Synthesized Mammography: Clinical Evidence, Appearance, and Implementation Durand, Melissa A. Diagnostics (Basel) Review Digital breast tomosynthesis (DBT) has improved conventional mammography by increasing cancer detection while reducing recall rates. However, these benefits come at the cost of increased radiation dose. Synthesized mammography (s2D) has been developed to provide the advantages of DBT with nearly half the radiation dose. Since its F.D.A. approval, multiple studies have evaluated the clinical performance of s2D. In clinical practice, s2D images are not identical to conventional 2D images and are designed for interpretation with DBT as a complement. This article reviews the present literature to assess whether s2D is a practical alternative to conventional 2D, addresses the differences in mammographic appearance of findings, and provides suggestions for implementation into clinical practice. MDPI 2018-04-04 /pmc/articles/PMC6023509/ /pubmed/29617294 http://dx.doi.org/10.3390/diagnostics8020022 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Durand, Melissa A.
Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title_full Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title_fullStr Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title_full_unstemmed Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title_short Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
title_sort synthesized mammography: clinical evidence, appearance, and implementation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023509/
https://www.ncbi.nlm.nih.gov/pubmed/29617294
http://dx.doi.org/10.3390/diagnostics8020022
work_keys_str_mv AT durandmelissaa synthesizedmammographyclinicalevidenceappearanceandimplementation